HCW Biologics Inc.
HCWB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,567 | $2,842 | $6,722 | $0 |
| % Growth | -9.7% | -57.7% | – | – |
| Cost of Goods Sold | $1,607 | $2,281 | $4,136 | $544 |
| Gross Profit | $959 | $560 | $2,586 | -$544 |
| % Margin | 37.4% | 19.7% | 38.5% | – |
| R&D Expenses | $6,389 | $7,676 | $9,338 | $7,820 |
| G&A Expenses | $21,945 | $13,084 | $7,988 | $0 |
| SG&A Expenses | $21,945 | $13,084 | $7,988 | $5,004 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,105 | $5,517 | $338 | $0 |
| Operating Expenses | $30,439 | $26,278 | $17,665 | $12,824 |
| Operating Income | -$29,480 | -$25,717 | -$15,079 | -$13,368 |
| % Margin | -1,148.5% | -905% | -224.3% | – |
| Other Income/Exp. Net | -$544 | $723 | $178 | $505 |
| Pre-Tax Income | -$30,024 | -$24,994 | -$14,901 | -$12,862 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30,024 | -$24,994 | -$14,901 | -$12,862 |
| % Margin | -1,169.7% | -879.5% | -221.7% | – |
| EPS | -0.77 | -0.7 | -0.41 | -0.35 |
| % Growth | -10% | -70.7% | -17.1% | – |
| EPS Diluted | -0.77 | -0.7 | -0.41 | -0.35 |
| Weighted Avg Shares Out | 38,793 | 35,929 | 35,822 | 35,768 |
| Weighted Avg Shares Out Dil | 38,793 | 35,929 | 35,822 | 35,768 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $505 |
| Interest Expense | $1,158 | $283 | $127 | $0 |
| Depreciation & Amortization | $1,184 | $1,135 | $718 | $544 |
| EBITDA | -$27,681 | -$23,576 | -$14,056 | -$12,319 |
| % Margin | -1,078.4% | -829.6% | -209.1% | – |